Reviva Historical Balance Sheet
| RVPH Stock | USD 1.37 0.03 2.24% |
Trend analysis of Reviva Pharmaceuticals Holdings balance sheet accounts such as Other Assets of 467.6 K, Total Current Assets of 15.2 M, Common Stock of 1.2 K or Property Plant Equipment of 731 provides information on Reviva Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Reviva Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Reviva Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Reviva Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Reviva Pharmaceuticals is a good buy for the upcoming year.
Reviva |
About Reviva Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Reviva Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Reviva Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Reviva Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Reviva currently owns. An asset can also be divided into two categories, current and non-current.
Reviva Pharmaceuticals Balance Sheet Chart
Reviva Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Reviva Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
As of now, Reviva Pharmaceuticals' Accounts Payable is increasing as compared to previous years. The Reviva Pharmaceuticals' current Other Assets is estimated to increase to about 467.6 K, while Retained Earnings are forecasted to increase to (127.6 M). Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Reviva Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Reviva Pharmaceuticals Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Reviva Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Reviva Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Reviva Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. As of now, Reviva Pharmaceuticals' Accounts Payable is increasing as compared to previous years. The Reviva Pharmaceuticals' current Other Assets is estimated to increase to about 467.6 K, while Retained Earnings are forecasted to increase to (127.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 2.3M | 6.0M | 17.2M | 18.0M | Other Current Liabilities | 1.8M | 2.5M | 2.9M | 3.0M |
Reviva Pharmaceuticals balance sheet Correlations
Click cells to compare fundamentals
Reviva Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Reviva Pharmaceuticals balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Liab | 101.5K | 324.7K | 1.8M | 2.5M | 2.9M | 3.0M | |
| Total Current Liabilities | 6.8M | 1.3M | 2.3M | 6.0M | 17.2M | 18.0M | |
| Net Tangible Assets | (35.9M) | 7.4M | 28.7M | 12.3M | 14.2M | 14.9M | |
| Retained Earnings | (54.5M) | (58.3M) | (66.8M) | (91.2M) | (134.4M) | (127.6M) | |
| Accounts Payable | 224.5K | 1.0M | 509.6K | 3.5M | 3.8M | 4.0M | |
| Total Current Assets | 193.0 | 8.8M | 31.4M | 18.9M | 23.7M | 15.2M |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Return On Assets (1.16) | Return On Equity (5.56) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.